ADAP

Question 1

Who is the CEO of Adaptimmune Therapeutics PLC?

Accepted Answer

Mr. Adrian Rawcliffe is the Chief Executive Officer of Adaptimmune Therapeutics PLC, joining the firm since 2015.

Question 2

What is the price performance of ADAP stock?

Accepted Answer

The current price of ADAP is $0.0485, it has decreased 0% in the last trading day.

Question 3

What are the primary business themes or industries for Adaptimmune Therapeutics PLC?

Accepted Answer

Adaptimmune Therapeutics PLC belongs to Biotechnology industry and the sector is Health Care

Question 4

What is Adaptimmune Therapeutics PLC market cap?

Accepted Answer

Adaptimmune Therapeutics PLC's current market cap is $12.8M

Question 5

Is Adaptimmune Therapeutics PLC a buy, sell, or hold?

Accepted Answer

According to wall street analysts, 3 analysts have made analyst ratings for Adaptimmune Therapeutics PLC, including 0 strong buy, 0 buy, 5 hold, 2 sell, and 0 strong sell

Adaptimmune Therapeutics PLC (ADAP) Price

ADAP Stock Price Chart

Follow-Up Questions

Who is the CEO of Adaptimmune Therapeutics PLC?

What is the price performance of ADAP stock?

What are the primary business themes or industries for Adaptimmune Therapeutics PLC?

What is Adaptimmune Therapeutics PLC market cap?

Is Adaptimmune Therapeutics PLC a buy, sell, or hold?

Follow-Up Questions

Who is the CEO of Adaptimmune Therapeutics PLC?

What is the price performance of ADAP stock?

What are the primary business themes or industries for Adaptimmune Therapeutics PLC?

What is Adaptimmune Therapeutics PLC market cap?

Is Adaptimmune Therapeutics PLC a buy, sell, or hold?